Brookeville, MD, United States of America

Drew M Pardoll

This inventor holds 53 USPTO granted patents and 30 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Cancer Immunotherapy (CPC class A61K). Top assignees: Johns Hopkins University, St. Jude Children's Research Hospital, University of South Florida. Active years: 1997-2025.

USPTO Granted Patents = 53 (Patent Applications = 30)

% Patents Active = 79.2

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 4.6

ph-index = 21

Forward Citations = 961(Granted Patents)

Forward Citations (Not Self Cited) = 882(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Baltimore, MD (US) (1997 - 2023)
Brookville, MD (US) (1999 - 2023)
Brookeville, MD (US) (1999 - 2023)

Company Filing History:

52 out of 3,790

Johns Hopkins University

patents

4 out of 280

St. Jude Children's Research Hospital

patents

2 out of 1,982

University of South Florida

patents

4. 2 out of 317

Whitehead Institute for Biomedical Research

6. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

Areas of Expertise:

Cancer Immunotherapy

Checkpoint Blockade

T Cell Modulation

YAP Inhibition

CAR Therapy

Biofilm Formation

Epigenetic Modulation

Dendritic Cells

Immune Response

Anti-Cancer Vaccine

STAT3 Signaling

Hematopoietic Stem Cells

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312398 - Compositions and methods for targeting activin signaling to treat cancer (2025-05-27),

2. 12186376 - Methods of treating or preventing cancer with an agent that depletes tregs and a checkpoint inhibitor (2025-01-07),

3. 11779555 - Combination of immunotherapy with local chemotherapy for the treatment of malignancies (2023-10-10),

4. 11753468 - Checkpoint blockade and microsatellite instability (2023-09-12),

5. 11730774 - Bacterial biofilms and cancer (2023-08-22),

6. 11718668 - Checkpoint blockade and microsatellite instability (2023-08-08),

7. 11649287 - Checkpoint blockade and microsatellite instability (2023-05-16),

8. 11643462 - Checkpoint blockade and microsatellite instability (2023-05-09),

9. 11634491 - Checkpoint blockade and microsatellite instability (2023-04-25),

10. 11629187 - Checkpoint blockade and microsatellite instability (2023-04-18),

11. 11591393 - Checkpoint blockade and microsatellite instability (2023-02-28),

12. 11491139 - Inhibition of YAP for breaking tumor immune tolerance (2022-11-08),

13. 11478548 - Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy (2022-10-25),

14. 11458227 - Compositions and methods for modulating wound healing and regeneration (2022-10-04),

15. 11346840 - Biofilm formation to define risk for colon cancer (2022-05-31),

Title: The Innovative Journey of Drew M. Pardoll

Introduction: Drew M. Pardoll, a distinguished male inventor hailing from Brookeville, MD (US), has made significant contributions to the field of innovations and inventions, particularly in the realm of healthcare and biotechnology.

Latest Patents: Drew M. Pardoll holds several groundbreaking patents in the field of immunotherapy, revolutionizing cancer treatment methods and paving the way for novel therapeutic approaches.

Career Highlights: With a stellar career in academia and research, Drew M. Pardoll has held prestigious positions at renowned institutions, where he has conducted pioneering research in immunology and oncology. His work has been instrumental in advancing the understanding of the immune system's role in cancer progression.

Collaborations: Throughout his career, Drew M. Pardoll has collaborated with leading scientists, researchers, and medical professionals to further his innovative research in cancer immunotherapy. His collaborative efforts have resulted in groundbreaking discoveries that have the potential to transform cancer treatment strategies.

Conclusion: Drew M. Pardoll's unwavering dedication to scientific innovation and his groundbreaking contributions to the field of immunotherapy have solidified his position as a trailblazing inventor in the realm of healthcare and biotechnology. His work continues to inspire future generations of inventors and researchers in the pursuit of innovative solutions to complex medical challenges.